Medical News

RSS

Low-dose semaglutide reduces alcohol consumption and cravings in early trial

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

13 Feb 2025

Is vaping the gateway to smoking?

The review highlights insufficient evidence for e-cigarettes as a gateway to smoking, calling for improved studies to guide effective public health regulations.

13 Feb 2025

Guardian molecule found to prevent cancer cells from changing identity

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational Brain Research (HITBR), and from the European Molecular Biology Laboratory (EMBL).

13 Feb 2025

Study identifies novel enhancers linked to neuropsychiatric disorders

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is an urgent need for effective and targeted therapies that can improve patients' quality of life.

13 Feb 2025

Older Americans find purpose and well-being in work, despite health barriers

Research shows older adults working past 65 experience significant health benefits and financial stability, highlighting the importance of supportive policies.

13 Feb 2025

Yourgene Health launches IONA Care+ non-invasive prenatal testing service

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal screening service for genetic conditions, in the UK.

13 Feb 2025

Selkirk Pharma introduces ClinFAST™ to expedite fill/finish for clinical trials

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the launch of ClinFAST™, a paradigm-shifting service designed to assist clinical stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies.

13 Feb 2025

Research shows early childcare boosts development in toddlers

For about 60 years, the prevailing wisdom in Japan, so-called "Three-Year-Old Myth," has held that children should be raised at home by their mothers until the age of three for healthy development.

13 Feb 2025

UCLA team identifies brain rhythms linked to seizures in Alzheimer's

A UCLA Health research team has identified changes in brain rhythms that indicate seizure activity in Alzheimer's patients.

13 Feb 2025

Natural supplement shows promise in treating heart disease

Heart transplant is a scary and serious surgery with high cost, but for patients with heart failure it can be the only option for cure.

13 Feb 2025

Oral vancomycin induces PSC-IBD remission, driving gut microbiome and metabolic shifts

Findings indicate oral vancomycin induces remission in PSC-IBD, with notable microbiota changes and inflammation reduction, reversing after treatment ends.

13 Feb 2025

Top California democrats clash over how to rein in drug industry middlemen

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.

13 Feb 2025

Republican states claim zero abortions. A red-state doctor calls that ‘ludicrous.’

In Arkansas, state health officials announced a stunning statistic for 2023: The total number of abortions in the state, where some 1.5 million women live, was zero.

13 Feb 2025

Cubic receives European patent for medical ultrasonic gas sensor

The patented V-shaped ultrasonic gas sensor technology by Cubic offers advanced measurement solutions, enhancing reliability in critical healthcare equipment.

From Cubic Sensor and Instrument Co. Ltd 13 Feb 2025

Montana looks to regulate prior authorization as patients, providers decry obstacles to care

When Lou and Lindsay Volpe's son was diagnosed with a chronic bowel disease at age 11, their health insurer required constant preapproval of drugs and treatments — a process the Volpes say often delayed critical care for their son.

13 Feb 2025

Study suggests sun exposure during first year of life may reduce MS relapses

Getting at least 30 minutes of daily summer sun in the first year of life may mean a lower relapse risk for children who are diagnosed with multiple sclerosis (MS) later, according to a study published on February 12, 2025, online in Neurology® Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology.

13 Feb 2025

Epidural steroid injections may offer modest short-term pain relief for some back pain

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people with certain kinds of chronic back pain.

13 Feb 2025

Brain aging linked to neuronal hyperactivation, not decline, study finds

A study of nematodes by researchers at Nagoya University in Japan has found that aging-related decline in brain function is caused by the excessive activation of certain neurons over time, rather than a decline in neuronal activity.

13 Feb 2025

Takumi-shaped DNA hydrogels show promise for targeted therapies

Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as sustained-release drug delivery systems as they can encapsulate various bioactive substances, including drugs, antigens, and even cells.

13 Feb 2025

KLX mitigates atherosclerotic progression by preventing EndMT

Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a significant cause of cardiovascular events.

13 Feb 2025